BDBM287743 US10085984, Example 121

SMILES: Fc1cc2nc(-c3cnnc4CCCc34)n(C3CC3)c2cc1F

InChI Key: InChIKey=PCQQHEQNQYZQRQ-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 287743   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cytochrome P450 11B2 (CYP11B2) (Homo sapiens (Human))	BDBM287743 (US10085984, Example 121 | US11040034, Ex. No. 121) Show SMILES Fc1cc2nc(-c3cnnc4CCCc34)n(C3CC3)c2cc1F Show InChI InChI=1S/C17H14F2N4/c18-12-6-15-16(7-13(12)19)23(9-4-5-9)17(21-15)11-8-20-22-14-3-1-2-10(11)14/h6-9H,1-5H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair
Cytochrome P450 11B1 (Homo sapiens (Human))	BDBM287743 (US10085984, Example 121 | US11040034, Ex. No. 121) Show SMILES Fc1cc2nc(-c3cnnc4CCCc34)n(C3CC3)c2cc1F Show InChI InChI=1S/C17H14F2N4/c18-12-6-15-16(7-13(12)19)23(9-4-5-9)17(21-15)11-8-20-22-14-3-1-2-10(11)14/h6-9H,1-5H2	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	5.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
Cytochrome P450 11B2 (Homo sapiens (Human))	BDBM287743 (US10085984, Example 121 | US11040034, Ex. No. 121) Show SMILES Fc1cc2nc(-c3cnnc4CCCc34)n(C3CC3)c2cc1F Show InChI InChI=1S/C17H14F2N4/c18-12-6-15-16(7-13(12)19)23(9-4-5-9)17(21-15)11-8-20-22-14-3-1-2-10(11)14/h6-9H,1-5H2	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	50	n/a	n/a	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
Cytochrome P450 11B1, mitochondrial (Homo sapiens (Human))	BDBM287743 (US10085984, Example 121 | US11040034, Ex. No. 121) Show SMILES Fc1cc2nc(-c3cnnc4CCCc34)n(C3CC3)c2cc1F Show InChI InChI=1S/C17H14F2N4/c18-12-6-15-16(7-13(12)19)23(9-4-5-9)17(21-15)11-8-20-22-14-3-1-2-10(11)14/h6-9H,1-5H2	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	750	n/a	n/a	n/a	n/a	n/a	n/a
Viamet Pharmaceuticals (Bermuda), Ltd. US Patent					Assay Description V79-4 cells expressing recombinant andrenodoxin and andrenodoxin reductase with either recombinant human CYP11B2 or CYP11B1 were prepared according t...				US Patent US10085984 (2018) BindingDB Entry DOI: 10.7270/Q2542QM2
					More data for this Ligand-Target Pair